The guidelines state that low adherence to ARV therapy is associated with detectable viral load, progression to AIDS, and death. Resistance to NNRTIs is more strongly linked to poor adherence than is resistance to unboosted PIs. Information on the effect of low adherence to integrase and entry inhibitors is not yet known.

An assessment of adherence can be made using self-report or a combination of questions answered through recall of pill-taking history over the period of a week or month. In supporting adherence, it helps to know if pills are missed because they are forgotten or avoided, due to side-effects.

Reducing barriers to adherence (e.g. depression, illicit drug use), simpler regimens (pills preferably taken once daily), an emphasis on integrating pill-taking into a daily routine, and an encouraging rather than judgemental attitude when asking about adherence are all seen as useful means of supporting adherence.  


Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap